The ERE-luc Reporter Mouse

  • P. Ciana
  • P. Mussi
  • M. Raviscioni
  • A. Biserni
  • L. Ottobrini
  • E. Vegeto
  • A. Maggi
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 46)


Estrogens, by signaling through two nuclear receptors (ERs), ERα and ERβ), can control specific gene networks and modulate target cell activities. In the last decade, cell-based approaches have provided major insights into the transcriptional regulation of ERs at the promoter of target genes where the interplay between ERs and coactivators and corepressors provides the receptors with tissue specificity of action. This is particularly highlighted by the analysis of transcription efficiency of synthetic ligands for ERs such as selective estrogen receptor modulators (SERMs) that may act as agonist in certain organs and antagonists in others. Furthermore, these molecular studies revealed a multiplicity of mechanisms controlling ER transcriptional activation (Maggi et al. 2004). Indeed, the cognate ligand, estrogen, appears not to be an absolute requirement for the activation of ERs (Bunone et al. 1996; Kato et al. 1995; Ma et al. 1994; Power et al. 1991). Several authors reported that growth factors through phosphorylation might stimulate unliganded ER to induce the transcription of selected target genes (Bunone et al. 1996; Kato et al. 1995; Patrone et al. 1996).


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bjornstrom L, Sjoberg M (2002) Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol 16:2202–2214PubMedCrossRefGoogle Scholar
  2. Bunone G, Briand PA, Miksicek RJ, Picard D (1996) Activation of the unli-ganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174–2183PubMedGoogle Scholar
  3. Burgess-Beusse B, Farrell C, Gaszner M, Litt M, Mutskov V, Recillas-Targa F, Simpson M, West A, Felsenfeld G (2002) The insulation of genes from external enhancers and silencing chromatin. Proc Natl Acad Sci 99 Suppl 4:16433–16437CrossRefGoogle Scholar
  4. Chung JH, Whiteley M, Felsenfeld G (1993) A 59 element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74:505–514PubMedCrossRefGoogle Scholar
  5. Ciana P, Di Luccio G, Belcredito S, Pollio G, Vegeto E, Tatangelo L, Tiveron C, Maggi A (2001) Engineering of a mouse for the in vivo profiling of estrogen receptor activity. Mol Endocrinol 15:1104–1113PubMedCrossRefGoogle Scholar
  6. Ciana P, Ghisletti S, Mussi P, Eberini I, Vegeto E, Maggi A (2003 a) ER-alpha, a molecular switch converting TGFalpha-mediated proliferation into differentiation in neuroblastoma cells. J Biol Chem 278:31737–31744 (Epub 2003 Apr 22)PubMedCrossRefGoogle Scholar
  7. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG, Lowik C, Maggi A (2003 b) In vivo imaging of transcriptionally active estrogen receptors. Nat Med 9:82–86PubMedCrossRefGoogle Scholar
  8. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA (1995) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66:523–531CrossRefGoogle Scholar
  9. Di Lorenzo D, Villa R, Biasiotto G, Belloli S, Ruggeri G, Albertini A, Apostoli P, Raviscioni M, Ciana P, Maggi A (2002) Isomer-specific activity of dichlorodyphenyltrichloroethane with estrogen receptor in adult and suckling estrogen reporter mice. Endocrinology 143:4544–4551PubMedCrossRefGoogle Scholar
  10. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masu-shige S, Gotoh Y, Nishida E, Kawashima H, Metzeger D, Chambon P (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491–1494PubMedCrossRefGoogle Scholar
  11. Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS (2002) Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-l)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J Biol Chem 277:8531–8537 (Epub 2001 Dec 21)Google Scholar
  12. Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A (1994) Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol 8:910–918PubMedCrossRefGoogle Scholar
  13. Maggi A, Ciana P, Belcredito S, Vegeto E (2004) Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu Rev (in press)Google Scholar
  14. McKay LI, Cidlowski JA (1998) Crosstalk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12:45–56PubMedCrossRefGoogle Scholar
  15. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292–1300PubMedGoogle Scholar
  16. Mussi P, Ciana P, Raviscioni M, Villa R, Regondi S, Agradi E, Maggi A, Di Lorenzo D (2003) Liver metabolization is an important step for the estrogenic activity of π,π’-DDT in vivo. Brain Res Bull (in press)Google Scholar
  17. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Skanlan TS (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at API sites. Science 277:1508–1510PubMedCrossRefGoogle Scholar
  18. Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A (1996) Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol Endocrinol 10:499–507PubMedCrossRefGoogle Scholar
  19. Patrone C, Tobias N, Cassel TN, Pettersson K, Ciana P, Maggi A, Warner M, Gustafsson J-Å, Nord M (2003) Estrogen regulates lung homeostasis via estrogen receptor a.α. Mol Cell Biol (in press)Google Scholar
  20. Power RF, Mani SK, Codina J, Connely OM, O’Malley BW (1991) Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254:1636–1639PubMedCrossRefGoogle Scholar
  21. Riggs BL, Hartmann LC (2003) Selective estrogen-receptor modulators -mechanisms of action and application to clinical practice. N Engl J Med 348:618–629PubMedCrossRefGoogle Scholar
  22. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK (2000) Interaction of estrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538–541PubMedCrossRefGoogle Scholar
  23. Stein B, Yang MX (1995) Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 15:4971–4979PubMedGoogle Scholar
  24. Stief A, Winter DM, Stratling WH, Sippel AE (1989) A nuclear DNA attachment element mediates elevated and position-independent gene activity. Nature 341:343–345PubMedCrossRefGoogle Scholar
  25. Sun FL, Elgin SC (1999) Putting boundaries on silence. Cell 99:459–462PubMedCrossRefGoogle Scholar
  26. Thompson JF, Hayes LS, Lloyd DB (1991) Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 103:171–177PubMedCrossRefGoogle Scholar
  27. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A et al. (2003) Estrogen receptor-alpha mediates the inhibitory activity of estradiol on brain macrophage reactivity. Proc Natl Acad Sci 100:9614–9619 (Epub 2003 July 23)Google Scholar
  28. Vos JG, Dybing E, Greim HA, Ladefoget O, Lambre C, Tarazona JV, Brandt I, Vethaak AD (2000) Health effects of endocrine-disrupting chemicals on wild-life, with special reference to the European situation. Crit Rev Toxicol 30:71–133PubMedCrossRefGoogle Scholar
  29. Wade CB, Robinson S, Shapiro RA, Dorsa DM (2001) Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology 142:2336–2342PubMedCrossRefGoogle Scholar
  30. Webb P, Lopez GN, Uht RM, Kushner PJ (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443–456PubMedCrossRefGoogle Scholar
  31. Wenger NK, Paoletti R, Lenfant CJM et al. (2002) International position paper on women’s health and menopause: a comprehensive approach. In: Wenger NK (ed) 1–23 NIH publication no. 02–3284.Google Scholar
  32. Bethesda, MD Wilson C, Bellen HJ, Gehring WJ (1990) Position effects on eukaryotic gene expression. Annu Rev Cell Biol 6:679–714PubMedCrossRefGoogle Scholar
  33. Wuttke W, Jarry H, Westphalen S, Christoffel V, Seidlova-Wuttke D (2002) Phytoestrogens for hormone replacement therapy? J Steroid Biochem Mol Biol 835:133–147CrossRefGoogle Scholar
  34. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW (2001) Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). J Biol Chem 276:27071–27076PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • P. Ciana
  • P. Mussi
  • M. Raviscioni
  • A. Biserni
  • L. Ottobrini
  • E. Vegeto
  • A. Maggi

There are no affiliations available

Personalised recommendations